Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2019-11-26 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 6728U' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the Major Shareholding Notification category. The presence of the RNS identifier and the nature of the content (reporting percentage changes in voting rights) strongly indicate this classification. It is not a full report (10-K, IR) nor a general announcement (RNS), but a specific regulatory filing about shareholdings.
2019-11-26 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and the explicit mention that 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details 'Director/PDMR Shareholdings' and provides specific notification details regarding the purchase and sale of ordinary shares by a Non-executive Director (Dr Trevor Nicholls). This directly corresponds to the definition of Director's Dealing (insider trades). Therefore, the appropriate filing type is DIRS.
2019-11-22 English
LG Chem Life Sciences Expands Partnership
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 1708T' and is dated '13 November 2019'. RNS stands for Regulatory News Service, which is the primary mechanism for listed companies in the UK (like Avacta Group plc, which is AIM-listed) to disseminate regulatory information to the market. The content is a press release providing an update on a partnership ('LG Chem Life Sciences Expands Partnership with Avacta') and includes contact details for brokers and PR firms, typical of a formal regulatory announcement. Although it contains business updates, its format and explicit reference to RNS strongly indicate it is a general regulatory filing/announcement, fitting the 'RNS' category best, as it is not a specific financial report (10-K, IR, ER) or a specific corporate action like a dividend or share transaction.
2019-11-13 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document explicitly starts with 'RNS Number : 8779S' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in major shareholdings, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification as MRQ over the general RNS fallback.
2019-11-11 English
Holding(s) in Company
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with "RNS Number : 8773S" and contains the standard format for a "TR-1: Standard form for notification of major holdings". This form is used to report changes in significant share ownership, which falls under regulatory disclosure requirements. The content details the resulting shareholding percentage (3.41%) and the date of the event. This type of mandatory disclosure, especially when originating from an RNS feed, is best classified as a general Regulatory Filing (RNS), as there is a more specific category for 'Major Shareholding Notification' (MRQ), but RNS is often used for standardized regulatory forms that might not fit perfectly elsewhere, or as the general category for LSE regulatory news service releases. Given the structure and the RNS header, RNS is appropriate, although MRQ is also highly relevant. Since TR-1 filings are standard regulatory disclosures disseminated via RNS, I will select RNS as the primary category for standardized regulatory announcements.
2019-11-08 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 8770S' and contains a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (Regulatory Filings), the specific content dictates the more precise classification of MRQ (Major Shareholding Notification). The document details the percentage change (from 3.46% to 4.53%) and the date the threshold was crossed (05 November 2019).
2019-11-08 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.